A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup-Reference-Cited by-同舟云学术

A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup

Published:2019-03-16 Issue:5 Volume:83 Page:951-962
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Lancia Carlo^ORCID,Anninga Jakob K.^ORCID,Sydes Matthew R.^ORCID,Spitoni Cristian^ORCID,Whelan Jeremy^ORCID,Hogendoorn Pancras C. W.^ORCID,Gelderblom Hans^ORCID,Fiocco Marta

Funder

Stichting Kinderen Kankervrij

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-019-03797-3.pdf

Reference28 articles.

1. Hryniuk WM, Goodyear M (1990) The calculation of received dose intensity. J Clin Oncol 8(12):1935–1937

2. Hryniuk WM, Frei E 3rd, Wright FA (1998) A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity. J Clin Oncol 16(9):3137–3147

3. Citron ML (2004) Dose density in adjuvant chemotherapy for breast cancer. Cancer Investig 22(4):555–568